Markets

VolitionRx Launches DETECSEPS Sepsis Detection Project With ~$7.3M French Government Funding

Sep 17, 2026 · 08:19 AM ET· updated 1h ago

French Government-Funded €6.3 million (~$7.3 million) Consortium Selects Volition's Nu.Q® NETs Assay as Sole Biomarker for France's Real World Evaluation of Early Detection of SepsisHENDERSON, Nev., Sept. 17,

Why It Matters

A French government group picked Volition's sepsis test for a new study. This shows hospitals may want to use their tool to catch serious infections early.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

VNRX0.29

+0.01 (+4.40%)

MMM164.05

+1.40 (+0.86%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.